Emcure Pharmaceuticals Ltd. (EMCURE): Emcure Pharmaceuticals Share Price rises 2.42% to Rs 1,956.40

Published: 18 September 2026 at 9:19:25 AM IST

Emcure Pharmaceuticals Share Price moved higher today, with the stock at Rs 1,956.40, up 2.42% from the previous close of Rs 1,910.10. The company’s market capitalisation stood at Rs 36,656.84 Cr. For readers tracking Emcure Pharmaceuticals Share Price Today, the move places the stock among the notable Stocks in News on the Indian Stock Market, even though the supplied data does not establish a company-specific catalyst. What the verified numbers do show is a higher close level relative to the prior day, a tight intraday range, and a modest turnover of Rs 0.27 Cr. In this Univest stock note, the emphasis is on what is factual: price movement, valuation context, sector positioning and peer comparison, rather than any unverified reason behind the rise.

The day began at Rs 1,912.00 and the stock moved between Rs 1,911.95 and Rs 1,957.45 before ending at Rs 1,956.40. That makes the Emcure Pharmaceuticals Share Price event a clear same-day price rise, useful for investors following Emcure Pharmaceuticals Stock News and Emcure Pharmaceuticals Share Price Live. Univest tracks such moves as part of broader Stock Market Today coverage, but the source data here only confirms the price event and the associated market statistics. It does not establish why the stock rose, and it does not attach the move to any external event, announcement or market reaction.

Emcure Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,956.4
Previous Close	Rs 1,910.1
Today's Move	Rs 46.3 (+2.42%)
Open	Rs 1,912
High	Rs 1,957.45
Low	Rs 1,911.95
Turnover	Rs 0.27 crore
Market Capitalisation	Rs 36,656.84 crore
Market Cap Category	Large Cap

Emcure Pharmaceuticals Ltd. (EMCURE) rose to Rs 1,956.4 from the previous close of Rs 1,910.1, a move of Rs 46.3 or 2.42%. The stock opened at Rs 1,912, reached a high of Rs 1,957.45, recorded a low of Rs 1,911.95.

Emcure Pharmaceuticals Share Price Today shows a gain of Rs 46.30, or 2.42%, versus the previous close. The stock opened close to the prior day’s level, stayed within a relatively narrow band for the session, and finished near the upper end of the day’s range. The highest trade recorded in the supplied data was Rs 1,957.45, while the lowest was Rs 1,911.95. In simple terms, the market data confirms a same-day Emcure Pharmaceuticals Share Price Rise without assigning a cause. The move also places the stock in current Market Movers discussions on Univest, where same-day changes are tracked through verified price, open, high, low and turnover figures. That is the right reading of today’s Emcure Pharmaceuticals Stock Performance: a factual advance in the share price, not a conclusion about what drove it.

Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 36,656.84 crore
P/E Ratio	35.83x
P/B Ratio	6.93x
ROE	20.09%
ROCE	25.25%
EPS	Rs 53.31
Book Value Per Share	Rs 275.72
Dividend Yield	0.19%

Emcure Pharmaceuticals Ltd. (EMCURE) fundamental metrics show P/E 35.83x, P/B 6.93x, ROE 20.09%, ROCE 25.25%. These figures provide context only and are not a buy or sell signal.

Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 36656.84 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 35.83x, P/B at 6.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.09% and ROCE of 25.25%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 53.31, book value per share of Rs 275.72, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	35.83x
Benchmark Median P/E	32.69x
Benchmark Average P/E	44.72x
Benchmark P/E Range	3.44x to 417.17x
Company P/B Ratio	6.93x
Benchmark Median P/B	3.1x
Company ROE	20.09%
Benchmark Median ROE	11.78%
Company ROCE	25.25%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 36,656.84 crore
Benchmark Median Market Cap	Rs 741.38 crore

Emcure Pharmaceuticals Ltd. (EMCURE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 35.83x, which is above the benchmark median of 32.69x, a difference of +9.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Emcure Pharmaceuticals Ltd. (EMCURE) has a ROE of 20.09%, which is above the benchmark median of 11.78%, a difference of +70.54%. Emcure Pharmaceuticals Ltd. (EMCURE) has a ROCE of 25.25%, which is above the benchmark median of 13.65%, a difference of +84.98%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	37.01	5.18	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,44,223.13	84.83	14.05	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,83,453.32	85.3	20.73	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,10,224.17	25.14	4.21	19.69	21.39
Cipla Ltd.	CIPLA	1,09,848.55	32.89	3.15	11.83	16

Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 35.83x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.09% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 25.25% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 36,656.84 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Emcure Pharmaceuticals

• The Emcure Pharmaceuticals Share Price rose 2.42% to Rs 1,956.40 from Rs 1,910.10.
• The stock printed a day high of Rs 1,957.45 and a day low of Rs 1,911.95.
• Market capitalisation stood at Rs 36,656.84 Cr.
• P/E was 35.83, P/B was 6.93, ROE was 20.09% and ROCE was 25.25%.
• In the same-industry benchmark, Emcure’s ROE and ROCE were above the median and average.

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company develops, manufactures and markets pharmaceutical products, which places it within a business category that investors often assess through earnings, margins, return ratios and industry comparisons. In the supplied data, the company’s financial profile includes a market capitalisation of Rs 36,656.84 Cr, EPS of Rs 53.31, book value of Rs 275.72 and dividend yield of 0.19%. Those figures help explain why the Emcure Pharmaceuticals Share Price is followed closely in Emcure Pharmaceuticals Latest News and Emcure Pharmaceuticals Company News coverage. In market commentary, the stock is often discussed through its earnings quality, valuation multiples and standing within the Indian pharmaceutical universe. Univest uses the same fact base to present a concise, research-style view of the business and its share price movement.

Track Emcure Pharmaceuticals Share Price on Univest

Use Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track the Emcure Pharmaceuticals Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels and market insights. The platform also brings together Emcure Pharmaceuticals Fundamental Analysis, company context and stock research in one place. That makes it easier to follow Emcure Pharmaceuticals Share Price Today alongside company financials and broader market updates without switching between sources. For users who monitor Emcure Pharmaceuticals NSE and Emcure Pharmaceuticals BSE references, Univest keeps the stock page structured for quick review and repeat checks.

Frequently Asked Questions

Why did Emcure Pharmaceuticals Share Price rise today?

Ans. The supplied data confirms that Emcure Pharmaceuticals Share Price rose 2.42% today, but it does not establish a company-specific catalyst. The move is reflected in price, open, high, low and previous close figures.

What is Emcure Pharmaceuticals Share Price today?

Ans. Emcure Pharmaceuticals Share Price today is Rs 1,956.40. It gained Rs 46.30, or 2.42%, versus the previous close of Rs 1,910.10, according to the supplied market data. The previous close was Rs 1,910.1.

What was the previous close for Emcure Pharmaceuticals?

Ans. The previous close for Emcure Pharmaceuticals was Rs 1,910.10. Today’s move took the stock above that level, with the session ending at Rs 1,956.40 and market capitalisation at Rs 36,656.84 Cr.

How much did Emcure Pharmaceuticals stock gain today?

Ans. Emcure Pharmaceuticals stock gained Rs 46.30 today, equal to 2.42%. The stock opened at Rs 1,912.00 and finished near the top of the day’s range at Rs 1,956.40. The previous close was Rs 1,910.1.

What does Emcure Pharmaceuticals Fundamental Analysis show?

Ans. Emcure Pharmaceuticals Fundamental Analysis shows P/E of 35.83, P/B of 6.93, ROE of 20.09%, ROCE of 25.25%, EPS of Rs 53.31 and book value of Rs 275.72. Dividend yield is 0.19%.

How does Emcure Pharmaceuticals compare with industry benchmarks?

Ans. In the same-industry benchmark, Emcure’s P/E is above the median of 32.69 and below the average of 44.72. ROE and ROCE are both above the industry median and average. The stock belongs to the Healthcare sector.

How does Emcure Pharmaceuticals compare with peers?

Ans. Emcure’s ROCE of 25.25% is higher than the supplied peers, while its P/E of 35.83 sits below Divi's and Torrent but above Zydus and Cipla. That gives the stock a mixed peer valuation profile.

Should investors track Emcure Pharmaceuticals Share Price on Univest?

Ans. Investors tracking Emcure Pharmaceuticals Share Price can use Univest for live price, valuation ratios, shareholding pattern and 52-week levels. The stock’s same-day rise makes it relevant for ongoing market monitoring.